Proapoptotic factor Fas ligand (FASL) and its cell surface receptor FAS are tumor necrosis factor superfamily members that trigger apoptosis in different cell types. However, their influence on luteal steroidogenesis is not clearly understood. The aim of the present work was to determine (i) the presence of the cytokine FASL and its receptor FAS in the mare's corpus luteum (CL) throughout the luteal phase, as well as (ii) the influence of FASL alone, or together with the cytokines tumor necrosis factor alpha (TNF) and interferon gamma (IFNG), on equine luteal cell production of luteotrophic and luteolytic factors, cell viability, and apoptosis. FASL and FAS protein expression and mRNA transcription were evaluated in different luteal stages of the equine CL by Western blotting and real-time PCR assays, respectively. Protein expression and FASL mRNA transcription increased in the late CL. Also, FAS and FASL proteins were present in large steroidogenic and endothelial CL cells throughout the luteal phase, as demonstrated by immunohistochemistry. Equine luteal cells isolated from midluteal phase CL were stimulated without (control) or with exogenous cytokines: FASL (10 ng/ml); TNF+IFNG (10 ng/ml each; positive control) or FASL+TNF+IFNG (10 ng/ml each). FASL clearly inhibited in vitro progesterone and prostaglandin E 2 (PGE 2 ) production by equine luteal cells but increased prostaglandin F 2alpha (PGF 2alpha ). Furthermore, FASL effect on equine luteal cell viability depended on the presence of cytokines TNF and IFNG. In conclusion, this study shows the presence of FASL and FAS in the equine CL and suggests their importance in functional luteolysis.
INTRODUCTION
During its life span, the corpus luteum (CL) goes through a rapid sequence of events, starting with its growth and establishment as an active endocrine organ. Its main function, progesterone (P 4 ) production, allows for the maintenance of pregnancy [1] . In the absence of gestation, CL regression, which is characterized by changes and degeneration of both vascular and steroidogenic cells, is essential for normal ovarian cyclicity and resumption of a new estrous cycle [2] [3] [4] .
The luteolytic process requires the participation of different triggering factors, very often acting synergistically in a complex way. The onset of luteal regression depends on luteolytic factors action, such as prostaglandin F 2a (PGF 2a ), nitric oxide [4, 5] , and cytokines [6] [7] [8] . Interferon gamma (IFNG) was shown as deleterious for bovine luteal cells, mainly cooperating with tumor necrosis factor alpha (TNF) in cell death [7] . As a result, a fall in P 4 production (functional luteolysis) and changes in luteal tissue morphology (structural luteolysis) occur during CL regression [3, 9, 10] .
Programmed cell death, or apoptosis, as a conserved mechanism among species, is essential for cell number and tissue size control and homeostasis maintenance. It is determinant for normal reproductive function and development in the ovary [11] . This process has been reported in CL involution in several species, such as mouse [12, 13] , rat [14, 15] , rabbit [16, 17] , sheep [18, 19] , cow [20, 21] , pig [22] , human [23] , and mare [24, 25] .
Two distinct signaling cascades can lead to apoptosis. In apoptosis intrinsic pathway, internal stimuli originated within the cell, promote changes in mitochondrial permeability [26] . However, in the extrinsic pathway, apoptosis is triggered when cytokine receptors, including tumor necrosis factor super family receptors (TNFRs), are activated [27] . TNF and Fas ligand (FASL) are cytokines mainly produced by immune cells [28] , which bind to cell surface receptors TNFR1 and FAS, respectively, and trigger apoptosis. This process starts with recruitment of cytoplasm proteins, which bind to death domain and to death effector domain [29] . Consecutively, it promotes the formation of death inducing signaling complex, which propagates the signaling cascade [30] . The formation of this complex activates downstream procaspase zymogens spreading the apoptotic signal, ending with the activation of effectors caspases [11, 25] .
In vivo studies have demonstrated the stimulatory action of FASL on structural regression in the mouse [31] and buffalo CL [32] . Also, in vitro research made clear the increase in FASL expression in cow luteolysis [33] . These data suggest an important role for FASL and FAS on structural involution and luteolysis. Nevertheless, the influence of FASL on steroidogenic capacity and functional luteolysis is not fully understood. Thus, the aim of the present work was to determine (i) the presence of the cytokine FASL and its receptor FAS in the mare's CL throughout the luteal phase, as well as (ii) the influence of FASL alone, or together with the cytokines TNF and IFNG, on equine luteal cell production of luteotrophic and luteolytic factors, and (iii) on cell viability and apoptosis mediation.
MATERIALS AND METHODS

Collection of Equine Corpora Lutea
Luteal tissue and venous blood from jugular veins were collected postmortem at the local abattoir from randomly designated cyclic Lusitano mares age 3-8 yr old from March (vernal equinox) until the end of August. The mares were euthanized after stunning according to the European legislation concerning welfare aspects of animal stunning and killing methods (EFSA, AHAW/04-027) and to the Portuguese legislation (DL 98/96, Art. 18), and approved by the Faculty of Veterinary Medicine Ethics Committee.
Luteal structures were classified based on plasma P 4 levels, follicle size, and the morphological appearance of the CL [34, 35] . Briefly, luteal tissue was considered as: early luteal phase CL (Early CL; presence of corpus hemorrhagicum, P 4 . 1 ng/ml, n ¼ 9), midluteal phase CL (Mid CL; CL associated with follicles 15-20 mm in diameter, P 4 . 6 ng/ml, n ¼ 15), and late luteal phase CL (Late CL; CL associated with preovulatory follicle 30-35 mm in diameter, P 4 between 1 and 2 ng/ml, n ¼ 9). Immediately after collection, luteal samples were included in specific solutions: (i) RNAlater (AM7020; Ambion; Applied Biosystems, Foster City, CA) for gene and protein expression quantification; (ii) transport media M199 (M2154; Sigma-Aldrich, St. Louis, MO) with 0.1% bovine serum albumin (BSA), 20 lg/ml gentamicin (G1397; Sigma), and 250 g/ml amphotericin (A2942; Sigma) for in vitro studies; or (iii) in buffered formaldehyde for immunostaining studies.
Experiment 1: FASL and FAS in the Equine CL
In order to study protein and gene expression of cytokines FASL and the receptor FAS in the equine CL, immunohistochemistry, Western blotting, and real-time PCR were carried out (Early CL, n ¼ 5; Mid CL, n ¼ 5; Late CL, n ¼ 5).
Immunohistochemistry analysis. As previously described, immunostaining studies were performed on consecutive 4-lm histological sections for the determination of FASL and FAS localization in luteal tissue [25] . The primary mouse monoclonal antibodies raised against FASL and the receptor FAS (556387 and 610197, respectively; BD Bioscience, Franklin Lakes, NJ) were diluted at 1:50 and 1:100 in 0.1 M PBS (pH 7.4), respectively. Negative control was performed by replacing the primary antibody by 0.1 M PBS (pH 7.4). Immunostaining was assessed as a characteristic brown staining of the cytoplasm and cell membrane, using a light microscope (BX51; Olympus, Tokyo, Japan) on 10 random fields at 4003 magnification. Microscopic fields were photographed (DP11; Olympus, Tokyo, Japan).
Western blotting. FAS and FASL protein expression on equine luteal tissue was assessed by Western blotting. After total protein concentration was determined, 100 lg of protein was loaded for FASL and 40 lg for FAS and for Beta-actin (b actin; A5441; Sigma) on a 12% acrylamide gel (161-0155; BioRad, Hercules, CA) and then transferred to nitrocellulose membranes (1620116; Bio-Rad) [36] . Level of active FASL was evaluated by using a polyclonal antibody raised in rabbit (sc-834; Santa Cruz Biotechnology, Santa Cruz, CA) and diluted 1:200, whereas for FAS quantification the same specific antibody for immunohistochemistry was used but diluted at 1:1000. For b actin a mouse monoclonal antibody was diluted 1:10 000. Membranes were incubated overnight at 48C. The secondary antibodies used were horseradish peroxidase (HRP)-conjugated anti-rabbit (P0448 Real-time PCR. Real-time PCR relative quantification was performed in order to assess FASL and FAS gene transcription in corpora lutea throughout the luteal phase. RNA was extracted from luteal tissue (Qiagen's Kit for Total RNA Extraction and Purification, 28704; Qiagen, Hilden, Germany) and DNA digested (RNase-free DNase Set, 50979254; Qiagen) according to the manufacturer's instructions. Later on, evaluation of RNA concentration was done spectrophotometrically (260 nm and 280 nm), and RNA quality was assessed by visualization of 28S and 18S rRNA bands after electrophoresis through a 1.5% gel agarose and ethidium bromide staining. Reverse transcription was carried out using Reverse Transcriptase Superscript III enzyme (18080093; Invitrogen; Gibco, Carlsbad, CA) from 1 lg total RNA in a 20 lL reaction volume using oligo (dT) primer (27-7858-01; GE Healthcare, Buckinghamshire, U.K.). Primer design was determined due to the lack of previously sequenced mRNA sequence for FASL and FAS genes in the horse in the Gene Bank Sequence Data Base (Gene DB). Degenerated primers (Table 1) were designed based on other species sequences deposited on Gene DB. Briefly, using CLC Free Workbench 3.2.3 software (CLC Bio, Aarhus, Denmark) [37] , conserved regions among species were identified after sequence alignment, and degenerated primers were designed using different Internet-based interfaces, such as Primer-3 [38] and Primer Premier software (Premier Biosoft Int., Palo Alto, CA) [39] . Several conventional PCR reactions using FideliTaq DNA polymerase master mix (71180; USB, Cleveland, OH) were carried out using a default thermocycler (Applied Biosystems) as follows: 2 min at 948C for denaturation; 35 cycles of 15 sec at 948C for enzyme activation, 45 sec at 448-558C for annealing (depending on the gene), and 45 sec at 688C for extension; and 5 min at 688C for finalization. Agarose (1%) (BIO-41025; Bioline, Luckenwalde, Germany) electrophoresis gel and ethidium bromide (17896; Thermo) staining showed a specific and single product. After purification using GFX PCR DNA and Gel Band Purification Kit (28903470; GE Healthcare, Buckinghamshire, U.K.), cDNA samples in duplicate were sent for sequenciation (Stabvida, Lisbon, Portugal). Sequences homology was confirmed and submitted to the GenBank at the National Center for Biotechnology Information (NCBI; Table 2). Specific primers were then chosen for these target genes and the housekeeping gene (HKG; Table 2 ).
To avoid genomic DNA amplification, primers were designed for two different exons, and all primer designs followed specific guidelines [40] . To determine the most stable internal control gene, under our experimental conditions three potential HKGs were initially considered (hypoxanthine phosphoribosyltransferase-1, b-actin, and b2-microglobulin-B2M). B2M gene transcription was unaffected by our experimental conditions, and therefore, elected as HKG.
Real-time PCR assays were performed in a 7300 Real Time PCR System (Applied Biosystems, Warrington, U.K.) using the default thermocycler program for all genes: a 10-min preincubation at 958C was followed by 40 cycles for 15 sec at 958C and 1 min at 608C. A further dissociation step (15 sec at 958C, 30 sec at 608C, and 15 sec at 958C) ensured the presence of a single product. In each real-time assay, both the target gene and HKG were run simultaneously. All reactions were carried out in duplicate wells on a 96-well optical reaction plate (4306737; Applied Biosystems) in 25 ll reaction volume: 6.5 ll water; 2 ll forward primer (160 nM); 2 lL reverse primer (160 nM); 12.5 ll Power SYBER Green Master Mix (Applied Biosystems, Ref. 4367659, UK) and 2 ll of cDNA. After analyzing the melting curves, PCR products were run through a 2.5% agarose gel to confirm specificity. Relative mRNA quantification data were then analyzed with the Real-time PCR Miner algorithm [41] . Primer concentration was previously optimized to the ratio minimum concentration/lowest cycle threshold.
Experiment 2: In Vitro Studies-Cell Culture Model Validation
In order to evaluate cytokine effect on luteal function, a luteal cell culture model with cells isolated from fresh CL was developed and optimized.
Connective tissue and blood clot (whenever present) were removed, and CL was minced into small pieces. Enzymatic digestion was performed for 50 min with M-199 (M2520; Sigma) with 0.1% (w/v) collagenase (C-0130; Sigma), 0.01% DNase I (D-5025; Sigma), and 0.1% (w/v) BSA (#735078; Roche Diagnostics GmbH, Mannheim, Germany) in Petri boxes at 378C. Every 10 min, dissociated cells were removed, and fresh medium containing enzymes was added. At the end, all collected cells were filtered twice with a Cell Dissociation Sieve-Tissue Grinder Kit (cd1-1kt; Sigma) through metal wire meshes (mesh 80, 190-lm opening size [S3770-5AE; Sigma] and mesh size 200, 73.7-lm opening size [S4145-5AE; Sigma]) to remove nondissociated tissue fragments. The filtrate was washed twice by centrifugation for 10 min at 180 g with M-199 with 0.1% BSA. Supernatant was discarded. Later, erythrocyte lyses was accomplished by washing the pellet with red blood lyses buffer (R7757; Sigma), and two further washing steps were performed. Cells were resuspended in Dulbecco modified Eagle medium (DMEM) and F-12 Ham medium (D/F medium; 1:1 [v/v]; D-8900; Sigma) containing 10% FBS (26140-079; Gibco) and gentamicin (20 lg/ml). Cell viability, determined by trypan blue exclusion dye (T8154; Sigma), was higher than 85%.
Dispersed luteal cells (2.0 3 10 5 /ml) were then cultured in 1 ml of D/F medium with 10% fetal calf serum, amphotericine (250 lg/ml), and gentamicin (20 lg/ml) in 24-well culture plates (142475; Nunc, Kamestrupvej, Denmark) at 378C with 5% CO 2 . In order to validate the cell culture model, luteal cells isolated from different luteal stages (Early CL, n ¼ 4; Mid CL, n ¼ 4; Late CL, n ¼ 4) were incubated for 24 h, with different concentrations of equine luteotrophic hormone (eLH; L9773; Sigma). This dose and time course study was performed 8 h after cell plating when cells adherent in a monolayer were 90%-95% confluent. Cells were washed with M-199 with 0.1% BSA and phenol red-free D/F medium (1:1; 11039; Gibco) with 0.1% BSA, gentamicin (20 lg/ml), and transferrin (T1428; 5 lg/ml; Sigma) added. After a 30-min stabilization period, cells were incubated with 1, 10, 50, or 100 ng/ml eLH for 8 or 24 h. Afterwards, conditioned media from negative control (no eLH added) and eLH treatment groups were stored at À308C until P 4 concentration assessment.
Experiment 3: Cytokines Stimulation
Experiment 3.1: cytokines stimulation dose assessment. To assess the adequate FASL (F0427; Sigma), TNF (T6674; Sigma), or IFNG (407306; Calbiochem, San Diego, CA) dose stimulation, luteal cells from Mid CL were cultured as described above and stimulated for 24 h as follows: no exogenous factor (control) or with each one of the individual cytokines (TNF, IFNG, and FASL) at three different concentrations (1 ng/ml, 10 ng/ml, and 50 ng/ml). Conditioned media by luteal cells were stored at À308C for further analysis. Experiment 3.2: cytokine effect on progesterone and prostaglandins release. In order to study cytokine effect on prostaglandins and progesterone release from the equine CL, luteal cell cultures from Mid CL (n ¼ 6) were stimulated for 24 h in a 5% CO 2 chamber with (i) no exogenous cytokines (negative control), (ii) FASL (10 ng/ml), (iii) TNFþINFG (10 ng/ml) as a positive control [7] , and (vi) FASLþTNFþIFNG (10 ng/ml). Conditioned media were stored at À708C until evaluation of P 4 , prostaglandin E 2 (PGE 2 ), and PGF 2a concentrations. 
FAS/Fas LIGAND SYSTEM IN CORPUS LUTEUM REGRESSION 903
WI) according to the manufacturer's manual. Absorbance (A) was read at 490 nm using a microplate reader (Model 450; Bio-Rad).
Poly (ADP-ribose) polymerase 1 (PARP1) assay kit (4677-096-k; R&D Systems, Abingdon, U.K.) was used in order to assess apoptosis. After a 24-h stimulation with cytokines (task performed after Experiment 3.2), Mid CL cells were scraped from the wells (541070; Greiner Bio-One, Monroe, NC) and kept in RNA at À708C until PARP1 activity quantification. Protein was extracted from the cells and quantified as described before [42] . According to the manufacturer's manual, a minimum of 20 lg of protein was used. PARP standard curve consisted of serial dilutions of PARP HAS-enzyme, and the negative control was PARP buffer without enzyme or cells. Absorbance was measured at 630 nm with a plate reader (KHB ST-360; Shanghai Kehua Laboratory System, Shanghai, China) at room temperature.
Hormone Determinations
Concentrations of P 4 , PGE 2 , and PGF 2a were determined directly from the cell culture media by direct enzyme immunoassay. As described previously [43] for P 4 concentration assessment, antiserum was used at a final dilution of 1:100 000. HRP-labeled P 4 was used at a final concentration of 1:75 000. The standard curve ranged from 0.39 to 100 ng/ml, and the concentration of P 4 at 50% binding (ED 50 ) was 4.1 ng/ml. The intra-and interassay coefficients of variation (CVs) were 5.5% and 8.5%, respectively. 
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Assessment of PGE 2 and PGF 2a concentrations followed the methodology previously described [44] . The PGE 2 standard curve ranged from 0.39 ng/ml to 100 ng/ml, and the ED 50 was 6.25 ng/ml. The intra-and interassay CVs were 1.6% and 11.0%, respectively. The PGF 2 standard curve ranged from 0.016 ng/ ml to 4 ng/ml, and the ED 50 was 0.25 ng/ml. The intra-and interassay CVs were on average 7.1% and 11.3%, respectively.
Statistical Analysis
Data regarding Western blotting analysis and real-time PCR in the luteal tissue, as well as P 4 , PGE 2 , and PGF 2 concentrations in culture medium and cell viability, were analyzed using one-way ANOVA followed by Bonferroni Multiple Comparison Test (GraphPAD PRISM, version 4.00; GraphPad Software, San Diego, CA). Statistical differences in mRNA and protein were compared by paired Student t-test (GraphPAD PRISM). Significance was defined as values of P , 0.05.
RESULTS
Experiment 1: FASL and FAS in the Equine CL
Immunohistochemistry analyses for active FASL and FAS showed that both the cytokine and its receptor were present in large luteal cells and endothelial cells throughout the luteal phase (Fig. 1) . No staining was present in either small luteal cells (Fig. 1f) or in negative controls (Fig. 1a) .
When comparing the different stages of the luteal phase, expression of FASL and FAS protein by Western blotting analysis showed that immunoreactive band intensity for FASL increased from Early to Late CL (P , 0.05; Fig. 2a ), but FAS protein expression did not change throughout the luteal phase (Fig. 2b) .
Assessment of FASL and FAS gene transcription in the mare's CL was possible after degenerated primers (Table 1) design and specific primers choice for these target genes and HKG, respectively (Table 2 ). In the mare's Early and Mid CL, FASL mRNA transcription was reduced with respect to Late CL (P , 0.05; Fig. 3a) , whereas its receptor FAS showed no changes (Fig. 3b) .
Experiment 2: In Vitro Studies-Cell Culture Model Validation
Different cellular components of the CL (small and large luteal cells, fibroblasts, endothelial cells, etc.) were isolated and cultured together in order to mimic an in vivo luteal environment as much as possible. After luteal cell isolation, about 25% of the isolated cells were large luteal cells in the early CL, whereas 70% were small luteal cells. Mid and Late CL consisted of 70% large luteal cells and 25% of small luteal cells. All eLH doses used to test the luteal cell culture model showed luteal cell viability and P 4 responsiveness. After a 24-h eLH Mid CL luteal cell stimulation, P 4 release was higher at the concentration of 10 ng/ml (P , 0.001; Fig. 4 ).
Experiment 3: Cytokines Stimulation
Experiment 3.1: cytokine stimulation dose assessment. This preliminary experiment allowed for the assessment of the most adequate cytokine stimulation dose. The concentration of 10 ng/ml for all cytokines studied was chosen because it showed the most consistent results (data not shown).
FIG. 5.
Mid CL luteal cell in vitro production of: P 4 (a), PGE 2 (b), and PGF 2a (c) after 24h stimulation by no exogenous cytokines (Control) or by FASL (10 ng/ml), TNFþIFNG (10 ng/ml of each), and FASLþTNFþIFNG (10 ng/ml of each). Bars represent mean 6 SEM. Asterisks indicate significant differences (*P , 0.05; **P , 0.01; ***P , 0.001).
FIG. 6. Equine Mid CL luteal cells viability (a) and PARP1 activity (b)
after a 24-h stimulation with cytokines at the concentration of 10 ng/ml. Control indicated by dashed line. Bars represent mean 6 SEM. Asterisks indicate significant differences (*P , 0.05; **P , 0.01; ***P , 0.001).
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steroidogenesis showed that FASL inhibited in vitro P 4 release (P , 0.05; Fig. 5a ). Nevertheless, when FASL was associated with other cytokines, no effect was observed. Regarding PGE 2 output from luteal cells, all treatments reduced its production when compared to negative controls (P , 0.05; Fig. 5b ). In contrast to this inhibitory effect, FASL stimulated PGF 2a output with respect to controls (P , 0.001; F i g . 5 c ) . T h e a s s o c i a t i o n o f t h r e e c y t o k i n e s (FASLþTNFþIFNG) was also capable of stimulating PGF 2a release, even though its effect was not as strong as when FASL was used alone (P , 0.05; Fig. 5c ).
Experiment 3.3: cytokine influence on cell viability and apoptosis. A reduction in luteal cell viability occurred when cells were exposed to the association of cytokines FASLþTNFþIFNG with respect to negative control (P , 0.01) or to positive control TNFþIFNG (P , 0.05; Fig. 6a ). Apoptosis, evaluated by PARP1 activity, showed a significant increase in cells stimulated with TNFþIFNG (P , 0.01) and the cytokine association FASLþTNFþIFNG (P , 0.001; Fig.  6b ).
DISCUSSION
To the best of our knowledge, this is the first study showing the presence of FASL and its receptor FAS in the equine CL and describing the cell types where they are expressed, as well as their mRNA transcription and protein expression profiles throughout the luteal phase. Moreover, the study of the effect of FASL, alone or together with other cytokines, on prostaglandins and P 4 production by Mid CL luteal cells helped to clarify the role of cytokine-receptor complex on mare CL regression. Their influence on luteal cell viability and apoptosis was also addressed. Like in other species, such as mouse, cow, or rat [11, 31, 33] , the cytokine FASL and its receptor FAS were expressed throughout the luteal phase in the mare. Their presence might indicate a physiological role during the luteal phase since biological activities of these molecules are dependent on their expression profiles. Okuda and Sakumoto [45] described the importance of TNF superfamily members on luteal events, including the establishment, maintenance, and regression of the CL. Other studies suggested that FAS-mediated apoptosis plays an important role in structural regression of the CL in a number of species [31, 33, 46] . Specifically, in the mare, both FASL mRNA transcription and protein expression increased toward the end of the luteal phase, whereas no significant changes were observed for the receptor FAS. This dramatic increase in FASL expression in the Late CL suggests its involvement in luteolysis in this species. Even though the FAS gene was transcripted and its protein expressed, no changes were present throughout the luteal phase.
Although the FAS/FASL system has been associated with CL structural regression [33, 46] , its precise role in luteal steroidogenic capacity during physiologic CL regression is lacking. In a study undertaken by Pru et al. [47] , FASL stimulation of bovine steroidogenic luteal cells had no effect on P 4 production. On the contrary, in the present study, equine Mid CL cell stimulation with FASL alone significantly reduced P 4 concentration in the culture medium. Also, in pseudopregnant mice, the in vivo administration of FAS-activating antibody decreased P 4 production [31] . In our study, after in vitro luteal cell stimulation with FASL alone, both luteotrophic factors P 4 [3] and PGE 2 [48] decreased, while the production of luteolytic hormone PGF 2a increased. This is the first evidence that FASL alone can influence luteal steroidogenesis and eicosanoid production in the mare, suggesting that FASL can work as an important regulator of functional luteolysis in the mare. The cytokine association TNFþIFNG, used as a positive control, has been tested in in vitro cytotoxicity studies [7, 49] . Also, cytokine synergic action on luteal PGF 2a stimulation has been shown in different species [7, 8, 50] . However, in the present study in the mare, TNFþIFNG only inhibited PGE 2 output, with no effect on PGF 2 production by the CL. When FASL was used together with the other cytokines (FASLþTNFþIFNG), a significant production of PGF 2 was seen as well as a PGE 2 reduction. Nevertheless, further studies should be performed in order to clarify the specific role of FASL on intraluteal synthesis of prostaglandins and P 4 and also of FASL interactions with other factors involved in CL regulation. Luteotrophic factors, like P 4 and PGE 2 , might have a protective role by preventing luteal cell vulnerability to apoptotic mechanisms, possibly regulating the ratio of proapoptotic:antiapoptotic gene translation and protein expression. Thus, equine luteal cell susceptibility to FASL action might depend on the absence of P 4 protective role, as shown before [10, 51, 52] . In the mare, the coordination between steroidogenic impairment and apoptosis during CL regression is complex and might depend on the temporal relationship among different factors/hormones and their concerted action during luteolysis.
In the present study, equine luteal cell stimulation with more than one cytokine always markedly reduced cellular viability. This synergic effect between cytokines on luteal cell viability reduction was also reported when TNF and IFNG increased FASL cytotoxic effect in cow [33] and murine luteal cells [53] . Nevertheless, in the cow, in disagreement with the present study, the deleterious effect of FASL alone on cell viability and the increase in apoptosis, after a 24-h stimulation, was shown [47] . In fact, in the present work, no agreement between luteal functional modulation and structural regulation was found. Cytokine FASL alone, after a 24-h incubation, was able to inhibit P 4 and PGE 2 output and reduce PGF 2a but had no effect on cell viability or apoptosis. We may speculate that if cells were submitted to FASL for longer incubation periods (48 h, 72 h) it would significantly affect cell viability and apoptosis. Therefore, this emphasizes the need for further studies. When comparing plasma P 4 pattern levels throughout the luteal phase between both species, it is evident that the luteolytic process in the mare starts earlier than in the cow. In the mare, P 4 starts dropping around day 11-12 of the cycle, after ovulation [54] , resulting in a long luteolytic process as well as a long follicular development period prior to ovulation. According to Ginther et al. [54] , in the mare, luteolysis is related to follicle estradiol production, and increase of which might be needed for structural regression to occur. Thus, association of these specific physiologic aspects in the mare might explain the different chronologic susceptibility of steroidogenic luteal cells to FASL apoptosis induction with respect to the cow. It was evident that the association between three cytokines (FASLþTNFþIFNG) was highly effective in triggering apoptosis in the mare. As shown in other species, such as cow [32, 55] or human [8, 56, 57] , the joint action of these cytokines seems to be a determinant for structural involution and luteolysis accomplishment.
In conclusion, the present work shows the presence of FASL and FAS in the equine CL and points out, for the first time, the important role of FASL on both functional and structural luteolysis. FASL alone can inhibit steroidogenesis and modulate PGF 2a and PGE 2 production in the equine corpus luteum. The physiologic luteal functional involution in the 906 mare is an intricate process with multiple intervenient factors/ hormones and actions that deserve to be further studied.
